Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity 2023-02-17 01:37
Immuno Cure kick off Phase I Clinical Trial in Shenzhen 2023-02-16 20:36
Oral Presentation at APASL Annual Meeting 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Achieve Functional Cure of Chronic Hepatitis B 2023-02-16 17:10
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck 2023-02-16 15:00
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe 2023-02-16 14:00
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial 2023-02-16 08:15
Innovent Announces First Patient Dosed in a Phase 3 Clinical Trial (CLEAR) of Picankibart (Anti-IL23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis 2023-02-16 08:00
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis 2023-02-15 21:30
Henlius Announces U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar Trastuzumab HLX02 2023-02-15 16:49
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS 2023-02-15 10:00
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy 2023-02-15 08:00
Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP) 2023-02-15 05:10
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine 2023-02-15 04:51
Eurofins Discovery Collaborating with Invasight on Cancer Therapies 2023-02-15 00:10
CJ Biomaterials Teams with Banila Co. to Develop New 100% Biobased Cosmetic Jar using Amorphous PHA 2023-02-14 22:00
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine 2023-02-13 21:00
Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 2023-02-13 15:02
Nippon Express Obtains GDP Certification of Compliance with WHO Standards at 2 Domestic Locations: West Japan Pharmaceutical Center and Kyushu Pharmaceutical Center 2023-02-10 14:00
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies 2023-02-10 09:34
Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy 2023-02-10 07:30
1 45 46 47 48 49 230